📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
1 articles
AVG GRADE
NEUTRAL
score: 0.00
SENTIMENT
NEUTRAL
TOTAL VIEWS
58
COLL Latest News & AI Sentiment Analysis
1 articles · Grade: NEUTRAL · Real-time AI-graded coverage
RECENT COVERAGE · 4 ARTICLES
Collegium Announces $50 Million Accelerated Share Repurchase Program
Collegium Pharmaceutical (COLL) announced execution of a $50 million accelerated share repurchase (ASR) agreement with Jefferies,...
Collegium Reports Second Quarter 2026 Financial Results and Highlights Recent Company Progress
Collegium Pharmaceuticals (COLL) reported Q2 2026 earnings alongside completion of the AZSTARYS acquisition, a strategic move that...
Collegium Pharmaceutical: Pain Cash Flows Are Funding An ADHD Re-Rating (NASDAQ:COLL)
Collegium Pharmaceutical (COLL) is executing a strategic portfolio shift that reorients the company toward higher-growth CNS and ADHD...
Third Avenue Small-Cap Value Fund Q2 2026 Commentary (TASCX)
The Third Avenue Small-Cap Value Fund (TASCX) delivered Q2 2026 performance of 12.85%, marginally outperforming the MSCI USA Small Cap...
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice